Intestinal MYC modulates obesity-related metabolic dysfunction-Reference-Cited by-同舟云学术

Intestinal MYC modulates obesity-related metabolic dysfunction

Published:2021-07 Issue:7 Volume:3 Page:923-939
ISSN:2522-5812
Container-title:Nature Metabolism
language:en
Short-container-title:Nat Metab

Author:

Luo Yuhong^ORCID,Yang Shoumei,Wu Xuan,Takahashi Shogo^ORCID,Sun Lulu^ORCID,Cai Jie,Krausz Kristopher W.,Guo Xiaozhen,Dias Henrique B.,Gavrilova Oksana,Xie Cen,Jiang Changtao^ORCID,Liu Weiwei^ORCID,Gonzalez Frank J.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Physiology (medical),Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://www.nature.com/articles/s42255-021-00421-8.pdf

Reference70 articles.

1. Ray, K. NAFLD—the next global epidemic. Nat. Rev. Gastroenterol. Hepatol. 10, 621 (2013).

2. Younossi, Z. et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11–20 (2018).

3. Anstee, Q. M., Targher, G. & Day, C. P. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat. Rev. Gastroenterol. Hepatol. 10, 330–344 (2013).

4. Wong, R. J., Cheung, R. & Ahmed, A. Non-alcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. Hepatology 59, 2188–2195 (2014).

5. Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M. & Sanyal, A. J. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med. 24, 908–922 (2018).

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: MYC as a disease target beyond cancer;Frontiers in Cell and Developmental Biology;2024-08-22

2. Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH;Cell Metabolism;2024-08

3. Endothelial c-Myc knockout disrupts metabolic homeostasis and triggers the development of obesity;Frontiers in Cell and Developmental Biology;2024-07-19

4. Ceramides are fuel gauges on the drive to cardiometabolic disease;Physiological Reviews;2024-07-01

5. Prohibitions in the meta-inflammatory response: a review;Frontiers in Molecular Biosciences;2024-05-15